Two Preventable Semaglutide Dosing Errors May Have Driven a Surge in Poison Control Calls

Poison control centers have seen a spike in calls related to semaglutide, a medication initially approved for diabetes but recently cleared for weight management. The surge appears linked to two common dosing mistakes: patients doubling up on doses or using a higher dose than prescribed. These errors underscore the importance of proper medical guidance when starting new medications, especially for those seeking weight loss benefits. The increase in calls highlights the need for better patient education and monitoring to prevent adverse effects.